HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist, blocks ANP-induced renal responses through a specific interaction with guanylyl cyclase-linked receptors
- 12 March 1992
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 225 (3) , 203-207
- https://doi.org/10.1016/0922-4106(92)90021-m
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Rat angiotensin II receptor: cDNA sequence and regulation of the gene expressionBiochemical and Biophysical Research Communications, 1991
- Microbial polysaccharide, HS-142-1, competitively and selectively inhibits ANP binding to its guanylyl cyclase-containing receptorBiochemical and Biophysical Research Communications, 1991
- Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptorNature, 1991
- Selective Activation of the B Natriuretic Peptide Receptor by C-Type Natriuretic Peptide (CNP)Science, 1991
- Biological characterization of human brain natriuretic peptide (BNP) and rat BNP: Species-specific actions of BNPBiochemical and Biophysical Research Communications, 1990
- C-Type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brainBiochemical and Biophysical Research Communications, 1990
- Atrial natriuretic factor plays a significant role in body fluid homeostasis.Hypertension, 1990
- The Biochemical Pharmacology of Atrial PeptidesAnnual Review of Pharmacology and Toxicology, 1989
- A membrane form of guanylate cyclase is an atrial natriuretic peptide receptorNature, 1989
- Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP)Biochemical and Biophysical Research Communications, 1984